[EN] 4-ETHYNYLPYRIDINE DERIVATIVES USEFUL AS GCN2 INHIBITORS<br/>[FR] DÉRIVÉS DE 4-ÉTHYNYLPYRIDINE UTILES EN TANT QU'INHIBITEURS DE GCN2
申请人:IP2IPO INNOVATIONS LTD
公开号:WO2021250399A1
公开(公告)日:2021-12-16
The invention provides compounds of formula I, wherein the substituents are as set out in further detail in the specification. The compounds are potent inhibitors of GCN2 and they have excellent pharmacokinetic properties. The compounds are useful for the treatment or prevention of a variety of conditions, particularly cancer. The invention further provides pharmaceutical compositions comprising the compounds of the invention and uses of the compounds and the compositions.
[EN] GPR 119 MODULATORS<br/>[FR] MODULATEURS DE GPR119
申请人:PFIZER
公开号:WO2010128425A1
公开(公告)日:2010-11-11
Compounds of Formula (I) that modulate the activity of the G-protein-coupled receptor GPR1 19 and their uses in the treatment of diseases linked to the modulation of the G-protein-coupled receptor GPR119 in animals are described herein.
[EN] GPR 119 MODULATORS<br/>[FR] MODULATEURS DU GPR119
申请人:PFIZER
公开号:WO2010128414A1
公开(公告)日:2010-11-11
Compounds of Formula (I) that modulate the activity of the G -protein-coupled receptor GPFM 19 and their uses in the treatment of diseases linked to the modulation of the G-protein-coupled receptor GPR119 in animals are described herein.
Compounds of Formula (I) that modulate the activity of the G-protein-coupled receptor GPR119 and their uses in the treatment of diseases linked to the modulation of the G-protein-coupled receptor GPR119 in animals are described herein.